A detailed history of New Square Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, New Square Capital LLC holds 134 shares of ABT stock, worth $15,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares
134
Previous 134 -0.0%
Holding current value
$15,695
Previous $13,000 15.38%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$100.73 - $112.44 $33,240 - $37,105
-330 Reduced 71.12%
134 $13,000
Q3 2023

Nov 03, 2023

SELL
$95.53 - $114.62 $49,675 - $59,602
-520 Reduced 52.85%
464 $44,000
Q2 2023

Aug 03, 2023

BUY
$100.78 - $112.29 $49,886 - $55,583
495 Added 101.23%
984 $107,000
Q4 2022

Feb 06, 2023

SELL
$95.06 - $111.52 $43,727 - $51,299
-460 Reduced 48.47%
489 $53,000
Q3 2022

Oct 25, 2022

SELL
$96.76 - $112.03 $64,442 - $74,611
-666 Reduced 41.24%
949 $92,000
Q1 2022

May 10, 2022

SELL
$114.02 - $139.04 $29,531 - $36,011
-259 Reduced 13.82%
1,615 $191,000
Q3 2021

Nov 08, 2021

BUY
$116.66 - $129.06 $51,913 - $57,431
445 Added 31.14%
1,874 $221,000
Q2 2021

Jul 28, 2021

BUY
$105.79 - $124.53 $19,994 - $23,536
189 Added 15.24%
1,429 $166,000
Q2 2020

Aug 05, 2020

SELL
$76.57 - $98.0 $64,242 - $82,222
-839 Reduced 40.36%
1,240 $113,000
Q1 2020

May 08, 2020

BUY
$62.82 - $91.86 $52,705 - $77,070
839 Added 67.66%
2,079 $164,000
Q3 2019

Oct 15, 2019

BUY
$81.84 - $88.74 $9,002 - $9,761
110 Added 9.73%
1,240 $104,000
Q2 2019

Aug 20, 2019

SELL
$72.88 - $85.0 $11,660 - $13,600
-160 Reduced 12.4%
1,130 $95,000
Q4 2018

Jan 22, 2019

BUY
$65.56 - $74.27 $10,489 - $11,883
160 Added 14.16%
1,290 $93,000
Q4 2017

Jan 29, 2018

BUY
$53.68 - $57.47 $56,739 - $60,745
1,057 Added 1447.95%
1,130 $64,000
Q3 2017

Nov 07, 2017

BUY
$48.06 - $53.64 $3,508 - $3,915
73
73 $4,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track New Square Capital LLC Portfolio

Follow New Square Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Square Capital LLC with notifications on news.